FI940192A0 - 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina - Google Patents
2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineinaInfo
- Publication number
- FI940192A0 FI940192A0 FI940192A FI940192A FI940192A0 FI 940192 A0 FI940192 A0 FI 940192A0 FI 940192 A FI940192 A FI 940192A FI 940192 A FI940192 A FI 940192A FI 940192 A0 FI940192 A0 FI 940192A0
- Authority
- FI
- Finland
- Prior art keywords
- alkonol
- hydroxypiperidino
- anesthetics
- derivatives
- alkonol derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73157791A | 1991-07-17 | 1991-07-17 | |
| PCT/US1992/004973 WO1993002052A1 (en) | 1991-07-17 | 1992-06-19 | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI940192L FI940192L (fi) | 1994-01-14 |
| FI940192A7 FI940192A7 (fi) | 1994-01-14 |
| FI940192A0 true FI940192A0 (fi) | 1994-01-14 |
Family
ID=24940103
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940192A FI940192A0 (fi) | 1991-07-17 | 1992-06-19 | 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina |
| FI981956A FI981956A0 (fi) | 1991-07-17 | 1992-06-19 | 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisia aineina |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI981956A FI981956A0 (fi) | 1991-07-17 | 1992-06-19 | 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisia aineina |
Country Status (22)
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436255A (en) * | 1992-07-23 | 1995-07-25 | Pfizer Inc. | Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
| PL173618B1 (pl) * | 1992-10-30 | 1998-04-30 | Pfizer | Związki 6-[2-(4-hydroksy-4-fenylopiperydyno)-1-hydroksypropylo]-3,4-dihydro-2(1H)-chinolonowe |
| US5498610A (en) * | 1992-11-06 | 1996-03-12 | Pfizer Inc. | Neuroprotective indolone and related derivatives |
| US6978166B2 (en) | 1994-10-07 | 2005-12-20 | Saint Louis University | System for use in displaying images of a body part |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| CA2220649C (en) * | 1996-12-03 | 2007-02-13 | F. Hoffmann-La Roche Ag | 4-hydroxy-piperidine derivatives |
| WO2000061558A1 (en) * | 1999-04-09 | 2000-10-19 | Mochida Pharmaceutical Co., Ltd. | Remedies for neuropathic pain |
| TWI254043B (en) * | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
| US6380205B1 (en) | 1999-10-29 | 2002-04-30 | Merck & Co., Inc. | 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
| US6432976B1 (en) | 1999-10-29 | 2002-08-13 | Merck & Co., Inc. | 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists |
| US6489477B1 (en) | 1999-10-29 | 2002-12-03 | Merck & Co., Inc. | 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists |
| US6316474B1 (en) | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
| US6291499B1 (en) | 1999-10-29 | 2001-09-18 | Merck & Co., Inc. | 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| US6369076B1 (en) | 1999-10-29 | 2002-04-09 | Merck & Co. Inc. | 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists |
| US6495561B2 (en) | 1999-10-29 | 2002-12-17 | Merck & Co., Inc. | 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
| US6362196B1 (en) | 1999-10-29 | 2002-03-26 | Merck & Co., Inc. | Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists |
| US6476041B1 (en) | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| DK1379520T3 (da) | 2001-02-23 | 2006-08-21 | Merck & Co Inc | N-substituerede ikke-aryl-heterocykliske NMDA/NR2B-antagonister |
| AU2002338334B8 (en) | 2001-04-03 | 2008-09-18 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists |
| ATE522502T1 (de) | 2002-11-25 | 2011-09-15 | Mochida Pharm Co Ltd | Therapeutisches mittel gegen atemwegserkrankungen,das ein 4-hydroxypiperidinderivat als wirkstoff enthält |
| JP2007508288A (ja) * | 2003-10-08 | 2007-04-05 | ファイザー株式会社 | 縮合ラクタム化合物 |
| TWI409289B (zh) | 2010-09-02 | 2013-09-21 | Taiwan Union Technology Corp | 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途 |
| IL299308A (en) * | 2020-06-23 | 2023-02-01 | Biohaven Therapeutics Ltd | Cutaneous formulations of (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| FR2546166B1 (fr) * | 1983-05-19 | 1985-10-25 | Synthelabo | Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique |
| FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
| ES2098248T3 (es) * | 1989-05-17 | 1997-05-01 | Pfizer | Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos. |
| WO1991017156A1 (en) * | 1990-05-10 | 1991-11-14 | Pfizer Inc | Neuroprotective indolone and related derivatives |
-
1992
- 1992-06-19 FI FI940192A patent/FI940192A0/fi unknown
- 1992-06-19 RU RU9294012366A patent/RU2065859C1/ru active
- 1992-06-19 AU AU23225/92A patent/AU655840B2/en not_active Ceased
- 1992-06-19 JP JP5502784A patent/JP2571904B2/ja not_active Expired - Lifetime
- 1992-06-19 FI FI981956A patent/FI981956A0/fi unknown
- 1992-06-19 EP EP92915510A patent/EP0594729A1/en not_active Ceased
- 1992-06-19 HU HU9400136A patent/HUT70528A/hu unknown
- 1992-06-19 CZ CS924008A patent/CZ284133B6/cs not_active IP Right Cessation
- 1992-06-19 BR BR9206272A patent/BR9206272A/pt not_active Application Discontinuation
- 1992-06-19 WO PCT/US1992/004973 patent/WO1993002052A1/en not_active Ceased
- 1992-06-19 PL PL92302290A patent/PL169884B1/pl unknown
- 1992-06-19 CA CA002113568A patent/CA2113568A1/en not_active Abandoned
- 1992-06-23 TW TW081104921A patent/TW201732B/zh active
- 1992-07-12 IL IL102473A patent/IL102473A/xx not_active IP Right Cessation
- 1992-07-15 PT PT100689A patent/PT100689B/pt not_active IP Right Cessation
- 1992-07-16 EG EG39792A patent/EG20048A/xx active
- 1992-07-16 CN CN92105921A patent/CN1043759C/zh not_active Expired - Fee Related
- 1992-07-16 MX MX9204190A patent/MX9204190A/es unknown
- 1992-07-16 ZA ZA925306A patent/ZA925306B/xx unknown
- 1992-07-16 IE IE231192A patent/IE922311A1/en not_active Application Discontinuation
- 1992-07-16 NZ NZ243580A patent/NZ243580A/en unknown
-
1994
- 1994-01-14 NO NO940144A patent/NO180445C/no not_active IP Right Cessation
- 1994-01-15 KR KR1019940700124A patent/KR0165003B1/ko not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI940192A0 (fi) | 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina | |
| FI924069L (fi) | Terapeutiskt anvaendbara peptider och peptidfragment | |
| FI921640L (fi) | Superabsorberande polymer med foerbaettrade absorptionsegenskaper | |
| FI930737A7 (fi) | Asialoglykoproteiiniin sidottu lääkeaine | |
| FI921038L (fi) | Foerfarande och anordning med bipolar menbraner foer elektrodialys foeraendringar | |
| FI923379L (fi) | Terapeutiska amider | |
| DE69222622D1 (de) | Spritze | |
| FI923581A7 (fi) | Farmaseuttinen yhdistelmämuodostelu | |
| FI924456A7 (fi) | Lääke | |
| FI943581A0 (fi) | Ruisku | |
| FI924744L (fi) | Terapeutiska aemnen | |
| NO940210D0 (no) | Lukke for medikamentbroenn | |
| FI923759L (fi) | Terapeutiska bensazapinfoereningar | |
| DE69229852D1 (de) | Vernetzbare Polymerzusammensetzung | |
| FI925827A7 (fi) | Silloitettavissa oleva polymeerikoostumus | |
| FI921786A7 (fi) | Farmaceutisk foerening | |
| FI921785A7 (fi) | Farmaceutisk foerening | |
| DK56591D0 (da) | Toerringsfremgangsmaade | |
| FI924614A7 (fi) | Vaermevaexlare med hoeg effekt och hygien | |
| FI931015A0 (fi) | 2-(2-substituerade pyrrolidinyltio)karbapenemderivat | |
| FI922425A7 (fi) | Uudet 14-kruunu-4-eetterijohdannaiset | |
| FI920701L (fi) | Anordning foer terapeutisk tryckbehandling | |
| KR920021041U (ko) | 세척기 | |
| NO942783D0 (no) | Spröyte | |
| NO924553L (no) | Avstembar mikroboelgeoscillator |